Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Avet Pharmaceuticals Inc., priced at $0.1535 per EA under NDC 23155087509. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
2.5 mg/1
Manufacturer
Avet Pharmaceuticals Inc.NDC
23155087509
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205869On Market Since
6/1/2023
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 133 times since Dec 13, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.1535 (Jun 24, 2026) |
| All-time low | $0.1225 (Jul 17, 2024) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1408 |
| Average price | $0.1389 |
| Largest weekly change | +16.5% (Aug 21, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Avet Pharmaceuticals Inc., is $0.1535 per EA (NDC 23155087509), effective Jun 24, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Dec 13, 2023, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1225 (Jul 17, 2024) to a high of $0.1535 (Jun 24, 2026), with a median of $0.1408 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LETROZOLE 2.5 MG TABLET, is $0.1203 per EA — about 22% below LETROZOLE 2.5 MG TABLET.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 23155087509) is labeled by Avet Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification